查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
细胞培养市场 - COVID-19 的增长、趋势、影响、预测 (2023-2028)
市场调查报告书
商品编码
1190253

细胞培养市场 - COVID-19 的增长、趋势、影响、预测 (2023-2028)

Cell Culture Market - Growth, Trends, and Forecasts (2023 - 2028)
出版日期: | 出版商: Mordor Intelligence | 英文 115 Pages | 商品交期: 2-3个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

在预测期内 (2022-2027)，细胞培养市场预计将以 11.0% 的复合年增长率增长。

随着 COVID-19 的爆发，世界各地的许多生物技术公司、製药公司、政府机构和研究机构开始专注于开发有效的疫苗和新型治疗药物以克服这一局面。 细胞培养可以作为开髮用于治疗 COVID-19 的新型疫苗的潜在平台。 此外，市场参与者在这个方向上采取的举措也对市场的增长产生了重大影响。 例如，2021 年 1 月，Captivate Bio 推出了一系列细胞培养工具，以帮助抗击美国的 COVID-19 和其他新兴疾病。 因此，COVID-19 对市场增长产生了显着影响。

对个性化医疗的需求不断增长，对疫苗、生物製药和人造器官的需求不断增长，再加上技术进步和产品/消耗品的推出等关键因素将推动预测期内的市场增长。正在推动

根据 GLOBOCAN 统计数据，2020 年全球估计有 1930 万新癌症病例，预计到 2040 年将达到 3020 万。 癌症的这种增长创造了对精准医疗的需求，并且随着细胞培养在个性化医疗的发展中发挥关键作用，预计未来几年对细胞培养的需求将会增加。 此外，药物和生物製药的积极研发也对市场增长做出了重大贡献。 例如，根据欧洲製药商协会联合会2022年的报告，欧洲製药业已支出396.56亿欧元的研发费用，预计2022年将达到415亿欧元。 这种对研发的日益关注创造了对细胞培养物来测试药物功效的需求，并正在推动市场的增长。

产品发布预计也将促进市场增长。 例如，2021 年 3 月，赛默飞世尔科技推出了一款新产品“Gibco 类人血浆培养基 (HPLM)”。 它是首批模拟人体血浆代谢曲线的细胞培养基之一，旨在为研究人员提供人体细胞生长的真实画面。

此外，技术先进和创新产品的推出也推动了市场的增长。 例如，2022 年 2 月，Nucleus Biologics 推出了 Krakatoa。 它是市场上第一家创新的培养基製造商之一，可帮助研究人员在使用时製造细胞培养基。

因此，由于上述因素，预计细胞培养市场在预测期内将呈现大幅增长。 然而，与细胞培养研究相关的高成本和新兴国家缺乏细胞培养研究的基础设施可能会阻碍市场增长。

主要市场趋势

预计药物开发部门在预测期内将快速增长。

细胞培养是医学研究和药物发现不可或缺的一部分。 药物开发是一个耗时且成本高昂的过程，需要经过多个阶段才能完成，从靶点识别到先导化合物的发现和优化、临床前验证、临床试验和临床使用批准。 基于细胞的高通量筛选 (HTS) 目前对在组织培养优化的塑料表面上以二维 (2D) 方式生长的培养细胞进行。 随着 3D 细胞培养的出现，HTS 过程变得更加简单和精确。

此外，政府对药物发现的支持也有助于这一细分市场的增长。 例如，2020 年 7 月，印度联邦政府发起了药物发现黑客马拉松“Nishank”。 此次黑客马拉松是全国首次支持药物发现过程，不仅得到了市场参与者的支持，也得到了各部委的支持。

此外，预计市场进入者的举措也将促进该细分市场的增长。 例如，2021 年 11 月，默克与 GI Innovation 签署了谅解备忘录 (MoU)，以促进韩国的生物医学发展。 根据谅解备忘录，默克将提供包括 CHOZN 平台、细胞培养基和下游工艺开发在内的技术和服务，以加速研发重要的挽救生命的癌症和过敏相关药物。 这些举措也有助于该部门的增长。

因此，由于上述因素，预计市场在预测期内将出现显着增长。

北美将在预测期内主导全球细胞培养市场

北美目前在细胞培养市场占据主导地位，预计在预测期内也将遵循同样的趋势。 这主要是由于对个性化医疗的需求不断增长，加上对疫苗、生物製药和人造器官的需求不断增加，以及市场上主要参与者的存在。

根据美国癌症协会2022年的统计数据，预计2022年美国将有1,918,030例癌症新发病例。 癌症等疾病负担的增加催生了对精准医疗的需求，导致对细胞培养产品及其开发耗材的需求增加，推动了市场增长。

市场进入者推出的产品预计也将促进市场增长。 例如，2020 年 12 月，eNuvio Canada 推出了首批完全可重复使用的 3D 细胞培养微孔板之一，即 EB-Plate。 预计此类发布将推动该地区的市场增长。 此外，2022 年 2 月，KromaTiD 推出了一套全面的细胞和血培养生长、分离、处理和质量控制服务。 公司推出此类产品和服务预计将推动市场增长，因为这也将增加对细胞培养产品和耗材的需求。

因此，由于上述因素，预计北美地区的细胞培养市场在预测期内将出现显着增长。

竞争格局

细胞培养市场竞争适中，由几家大型企业组成。 从市场份额的角度来看，目前几家大型企业占据了市场主导地位。 Thermo Fisher Scientific、Danaher Corporation、Sartorius AG、Merck KGaA 等主要市场参与者的存在也加剧了整个市场竞争对手之间的竞争。 此外，主要参与者的产品改进和细胞培养平台改进也加剧了竞争。

其他福利。

  • Excel 格式的市场预测 (ME) 表
  • 三个月的分析师支持

内容

第一章介绍

  • 研究假设和市场定义
  • 调查范围

第二章研究方法论

第 3 章执行摘要

第四章市场动态

  • 市场概览
  • 市场驱动力
    • 对疫苗、生物製药和人造器官的需求不断增长
    • 对个性化医疗越来越感兴趣
  • 市场製约因素
    • 与基于细胞的研究相关的高成本
    • 新兴国家/地区缺乏基于细胞的研究基础设施
  • 行业吸引力 - 波特五力分析
    • 买方/消费者议价能力
    • 供应商的议价能力
    • 新进入者的威胁
    • 替代品的威胁
    • 竞争公司之间的敌对关係

第 5 章市场细分（基于价值的市场规模：100 万美元）

  • 按产品和消耗品
    • 按产品分类
      • 生物安全设备
      • 离心机
      • 低温储存设备
      • 培养系统/生物反应器
      • 孵化器
      • 管道设备
      • 其他
    • 消耗品
      • 中等
      • 血清
      • 试剂
  • 通过申请
    • 生物製药
    • 药物开发
    • 基因治疗
    • 组织培养与工程
    • 疫苗製造
    • 其他用途
  • 按地区
    • 北美
      • 美国
      • 加拿大
      • 墨西哥
    • 欧洲
      • 德国
      • 英国
      • 法国
      • 意大利
      • 西班牙
      • 其他欧洲地区
    • 亚太地区
      • 中国
      • 日本
      • 印度
      • 澳大利亚
      • 韩国
      • 其他亚太地区
    • 中东和非洲
      • 海湾合作委员会
      • 南非
      • 其他中东地区
    • 南美洲地区
      • 巴西
      • 阿根廷
      • 其他南美洲

第六章竞争格局

  • 公司简介
    • Biospherix
    • Hi-Media Laboratories
    • Merck KGaA
    • Promocell GmbH
    • Sartorius AG
    • Thermo Fisher Scientific
    • Danaher Corporation
    • Sekisui XenoTech LLC
    • Lonza Group
    • Agilent Technologies Inc.
    • Becton, Dickinson and Company
    • Cytiva
    • Corning Incorporated

第7章 市场机会今后动向

简介目录
Product Code: 67166

The cell culture market is expected to witness a CAGR of 11.0% over the forecast period (2022-2027).

With the onset of COVID-19, many biotech and pharmaceutical firms, government organizations in various countries, and research institutes started to focus on the development of effective vaccines and new therapeutics to overcome the situation. Cell culture may serve as a potential platform for the development of novel vaccines for the treatment of COVID-19. Additionally, initiatives taken by the market players in such directions also led to a significant impact on the market's growth. For instance, in January 2021, Captivate Bio launched its portfolio of cell culture tools to assist in the fight against COVID-19 and other emerging diseases in United States. Thus, COVID-19 had a pronounced impact on the growth of the market.

The major factors such as the growing demand for personalized medicine coupled with the rise in the demand for vaccines, biopharmaceuticals, and artificial organs coupled with the advancement in technology and the launch of products and consumables are driving the growth of the market over the forecast period.

According to GLOBOCAN Statistics, there were an estimated 19.3 million new cases of cancer around the world in the year 2020, and it is projected to reach 30.2 million by 2040. Such an increasing burden of cancer creates the need for precision medicine, so the demand for cell culture is expected to increase over the coming years as cell culture plays a vital role in the development of personalized medicine. Additionally, increasing research and development in pharmaceuticals and biopharmaceuticals also contributes largely to the growth of the market. For instance, according to the European Federation of Pharmaceutical Industries and Associations, 2022 report, the pharmaceutical industry in Europe incurred expenses of EUR 39,656 million for its research and development, and for 2022, this expense is expected to be EUR 41,500 million. Such an increasing focus on research and development creates the need for cell cultures for testing the effectiveness of the drug and thus drives the growth of the market.

The launch of products is also expected to drive the growth of the market. For instance, in March 2021, Thermo Fisher Scientific launched its new Gibco Human Plasma-like Medium (HPLM). It is one of the first types of cell culture medium that mimics the metabolic profile of human plasma and is designed to provide researchers with a realistic view of cell growth within the human body. ​

Additionally, the launch of technologically advanced and innovative products also propels the growth of the market. For instance, in February 2022, Nucleus Biologics launched Krakatoa. It is an innovative, one of the first to market media makers that helps researchers to manufacture cell culture media at the point of use.

Thus, owing to the abovementioned factors, the cell culture market is expected to show considerable growth over the forecast period. However, the high cost associated with cell-based research and the lack of infrastructure for cell-based research in emerging economies may impede the growth of the market.

Key Market Trends

Drug Development Segment is Expected to Witness Rapid Growth Over the Forecast Period.

Cell culture is an integral part of medical research and drug discovery. Drug development is a time-consuming and costly procedure that is completed in multiple stages, from target identification to lead discovery and optimization, preclinical validation, and clinical trials, culminating in approval for clinical use. Cell-based high throughput screening (HTS) is currently being carried out on cultured cells propagated in two dimensions (2D) on plastic surfaces optimized for tissue culture. With the emergence of 3D cell culture, the process of HTS has become easier and more accurate.

Furthermore, the support from the governments of different countries for drug discovery is also contributing to the growth of the segment. For instance, in July 2020, the Union Government of India launched the Drug Discovery Hackathon "Nishank". This Hackathon is a first-of-its-kind national initiative for supporting the drug discovery process and is supported by various departments as well as market players.

Additionally, the initiatives taken by the market players are also expected to boost the growth of the market segment. For instance, in November 2021, Merck signed a Memorandum of Understanding (MoU) with GI Innovation, to facilitate biomedicine development in Korea. As per the MoU, Merck provides technologies and services, including the CHOZN platform, cell culture media, and downstream process development, to promote research and development of critical life-saving cancer treatments, as well as drugs for allergy-related conditions. Such initiatives also contribute to the growth of the segment.

Thus, owing to the abovementioned factors, the market segment is expected to project significant growth over the forecast period.

North America Dominates the Global Cell Culture Market Over the Forecast Period

North America is currently dominating the cell culture market and is expected to follow the same trend over the forecast period. This is majorly attributed to the growing demand for personalized medicine coupled with the rise in the demand for vaccines, biopharmaceuticals, and artificial organs, and the presence of key players in the market.

According to the American Cancer Society's 2022 statistics, there will be an estimated 1,918,030 new cases of cancer in United States in 2022. Such an increasing burden of diseases such as cancer creates the need for precision medicine, which leads to the increase in demand for cell culture products and consumables for their development and hence drives the growth of the market.

The launch of products by the market players is also expected to drive the growth of the market. For instance, in December 2020, eNuvio Canada launched one of the first completely reusable 3D cell culture microplates, namely the EB-Plate. Such launches are expected to propel the growth of the market in the region. Additionally, in February 2022, KromaTiD launched a comprehensive suite of cell and blood culture growth, isolation, processing, and quality control services. The launch of such products and services by the companies also boosts the demand for cell culture products and consumables and is thus expected to drive the growth of the market.

Thus, owing to the abovementioned factors, the studied market in the North American region is expected to show considerable growth over the forecast period.

Competitive Landscape

The cell culture market is moderately competitive and consists of several major players. In terms of market share, a few of the major players currently dominate the market. The presence of major market players, such as Thermo Fisher Scientific, Danaher Corporation, Sartorius AG, Merck KGaA, and others, also increases the overall competitive rivalry of the market. Additionally, the product advancements and improvements in cell culture platforms by the major players are also increasing the competition.

Additional Benefits:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 Study Assumptions and Market Definition
  • 1.2 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Rise in the Demand for Vaccines, Biopharmaceuticals and Artificial Organs
    • 4.2.2 Growing Focus on Personalized Medicine
  • 4.3 Market Restraints
    • 4.3.1 High Cost Associated with Cell Based Research
    • 4.3.2 Lack of Infrastructure for Cell-based Research in Emerging Economies
  • 4.4 Industry Attractiveness - Porter's Five Forces Analysis
    • 4.4.1 Bargaining Power of Buyers/Consumers
    • 4.4.2 Bargaining Power of Suppliers
    • 4.4.3 Threat of New Entrants
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION (Market Size by Value - USD million)

  • 5.1 By Product and Consumables
    • 5.1.1 Product
      • 5.1.1.1 Biosafety Equipment
      • 5.1.1.2 Centrifuges
      • 5.1.1.3 Cryostorage Equipment
      • 5.1.1.4 Culture Systems/Bioreactors
      • 5.1.1.5 Incubators
      • 5.1.1.6 Pipetting Instruments
      • 5.1.1.7 Others
    • 5.1.2 Consumables
      • 5.1.2.1 Media
      • 5.1.2.2 Sera
      • 5.1.2.3 Reagents
  • 5.2 By Application
    • 5.2.1 Biopharmaceuticals
    • 5.2.2 Drug Development
    • 5.2.3 Gene Therapy
    • 5.2.4 Tissue Culture and Engineering
    • 5.2.5 Vaccine Production
    • 5.2.6 Other Applications
  • 5.3 Geography
    • 5.3.1 North America
      • 5.3.1.1 United States
      • 5.3.1.2 Canada
      • 5.3.1.3 Mexico
    • 5.3.2 Europe
      • 5.3.2.1 Germany
      • 5.3.2.2 United Kingdom
      • 5.3.2.3 France
      • 5.3.2.4 Italy
      • 5.3.2.5 Spain
      • 5.3.2.6 Rest of Europe
    • 5.3.3 Asia-Pacific
      • 5.3.3.1 China
      • 5.3.3.2 Japan
      • 5.3.3.3 India
      • 5.3.3.4 Australia
      • 5.3.3.5 South Korea
      • 5.3.3.6 Rest of Asia-Pacific
    • 5.3.4 Middle East and Africa
      • 5.3.4.1 GCC
      • 5.3.4.2 South Africa
      • 5.3.4.3 Rest of Middle East and Africa
    • 5.3.5 South America
      • 5.3.5.1 Brazil
      • 5.3.5.2 Argentina
      • 5.3.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 Biospherix
    • 6.1.2 Hi-Media Laboratories
    • 6.1.3 Merck KGaA
    • 6.1.4 Promocell GmbH
    • 6.1.5 Sartorius AG
    • 6.1.6 Thermo Fisher Scientific
    • 6.1.7 Danaher Corporation
    • 6.1.8 Sekisui XenoTech LLC
    • 6.1.9 Lonza Group
    • 6.1.10 Agilent Technologies Inc.
    • 6.1.11 Becton, Dickinson and Company
    • 6.1.12 Cytiva
    • 6.1.13 Corning Incorporated

7 MARKET OPPORTUNITIES AND FUTURE TRENDS